NCT04977271 2025-02-04
Mood Disorders in Head and Neck Cancer Patients
University of Alabama at Birmingham
Phase 4 Withdrawn
Clinical Trials
3 trialsNCT05724849 2024-01-18
Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
Vanderbilt University Medical Center
Phase 2 Withdrawn
NCT03574792 2021-12-09
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Roswell Park Cancer Institute
Phase NA Completed